Trinity College, Oxford OX1 3BH
Five 40-minute slots are available for companies developing new point-of-care diagnostic technology for antimicrobial resistance (AMR) with a community focus. Discussions will cover next steps in evidence generation and potential for collaboration. The aim is to take promising technologies forward into joint funding applications.
Organised by the NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative
Further information and booking details here.